share_log

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Commercial Officer Smolinski Stephen

Jan 6, 2022 16:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more